| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Mineralys Therapeutics, Inc.
13G/A
MLYS · 603170101
|
10.1% |
2/13/2026
Event 12/31/2025
|
||||
| Catalys Pacific Fund, LP | 10.1% | |||||
| Catalys Pacific Fund GP, LP | 10.1% | |||||
| Catalys Pacific, LLC | 10.1% | |||||
| Brian Taylor Slingsby | 10.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.